Vagus nerve stimulation in pediatric intractable epilepsy

a Korean bicentric study.

hoonchul kang, Y. S. Hwang, D. S. Kim, HeungDong Kim

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To present our experience with vagus nerve stimulation (VNS) and to evaluate the long-term efficacy and safety of the procedure in pediatric intractable epilepsy. METHODS: This study included sixteen patients, who were implanted with a vagus nerve stimulator and could be followed up for at least more than 12 months in two epilepsy centers. Data including seizure frequency, EEG, quality of life measures and adverse events were prospectively filed over a 5-year period. RESULTS: VNS resulted in a > 50% reduction in seizure frequency in 50.0% (8/16) of children with 31.3% (5/16) of patients achieving a > 90% reduction. Additionally, enhancements in quality of life were as follows: memory in 50.0% (8/16), mood in 62.5% (10/16), behavior in 68.8% (11/16), alertness in 68.8% (11/16), achievement in 37.5% (6/16), and verbal skills in 43.8% (7/16) of the patients. Adverse events included hoarseness in two patients, dyspnea during sleep in two patients, and sialorrhea in one patient. However, these events were tolerable or could be controlled by the adjustment of output currents. In one patient, wound revision was required. CONCLUSION: Our data supports the role of VNS as an alternative therapy for pediatric intractable epilepsy.

Original languageEnglish
Pages (from-to)93-96
Number of pages4
JournalActa neurochirurgica. Supplement
Volume99
Publication statusPublished - 2006 Dec 1

Fingerprint

Vagus Nerve Stimulation
Pediatrics
Seizures
Quality of Life
Sialorrhea
Social Adjustment
Hoarseness
Vagus Nerve
Complementary Therapies
Drug Resistant Epilepsy
Dyspnea
Electroencephalography
Epilepsy
Sleep
Safety
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

@article{07096513d8284f5098bf3c96924d0c51,
title = "Vagus nerve stimulation in pediatric intractable epilepsy: a Korean bicentric study.",
abstract = "OBJECTIVE: To present our experience with vagus nerve stimulation (VNS) and to evaluate the long-term efficacy and safety of the procedure in pediatric intractable epilepsy. METHODS: This study included sixteen patients, who were implanted with a vagus nerve stimulator and could be followed up for at least more than 12 months in two epilepsy centers. Data including seizure frequency, EEG, quality of life measures and adverse events were prospectively filed over a 5-year period. RESULTS: VNS resulted in a > 50{\%} reduction in seizure frequency in 50.0{\%} (8/16) of children with 31.3{\%} (5/16) of patients achieving a > 90{\%} reduction. Additionally, enhancements in quality of life were as follows: memory in 50.0{\%} (8/16), mood in 62.5{\%} (10/16), behavior in 68.8{\%} (11/16), alertness in 68.8{\%} (11/16), achievement in 37.5{\%} (6/16), and verbal skills in 43.8{\%} (7/16) of the patients. Adverse events included hoarseness in two patients, dyspnea during sleep in two patients, and sialorrhea in one patient. However, these events were tolerable or could be controlled by the adjustment of output currents. In one patient, wound revision was required. CONCLUSION: Our data supports the role of VNS as an alternative therapy for pediatric intractable epilepsy.",
author = "hoonchul kang and Hwang, {Y. S.} and Kim, {D. S.} and HeungDong Kim",
year = "2006",
month = "12",
day = "1",
language = "English",
volume = "99",
pages = "93--96",
journal = "Acta Neurochirurgica, Supplement",
issn = "0065-1419",
publisher = "Springer Wien",

}

Vagus nerve stimulation in pediatric intractable epilepsy : a Korean bicentric study. / kang, hoonchul; Hwang, Y. S.; Kim, D. S.; Kim, HeungDong.

In: Acta neurochirurgica. Supplement, Vol. 99, 01.12.2006, p. 93-96.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vagus nerve stimulation in pediatric intractable epilepsy

T2 - a Korean bicentric study.

AU - kang, hoonchul

AU - Hwang, Y. S.

AU - Kim, D. S.

AU - Kim, HeungDong

PY - 2006/12/1

Y1 - 2006/12/1

N2 - OBJECTIVE: To present our experience with vagus nerve stimulation (VNS) and to evaluate the long-term efficacy and safety of the procedure in pediatric intractable epilepsy. METHODS: This study included sixteen patients, who were implanted with a vagus nerve stimulator and could be followed up for at least more than 12 months in two epilepsy centers. Data including seizure frequency, EEG, quality of life measures and adverse events were prospectively filed over a 5-year period. RESULTS: VNS resulted in a > 50% reduction in seizure frequency in 50.0% (8/16) of children with 31.3% (5/16) of patients achieving a > 90% reduction. Additionally, enhancements in quality of life were as follows: memory in 50.0% (8/16), mood in 62.5% (10/16), behavior in 68.8% (11/16), alertness in 68.8% (11/16), achievement in 37.5% (6/16), and verbal skills in 43.8% (7/16) of the patients. Adverse events included hoarseness in two patients, dyspnea during sleep in two patients, and sialorrhea in one patient. However, these events were tolerable or could be controlled by the adjustment of output currents. In one patient, wound revision was required. CONCLUSION: Our data supports the role of VNS as an alternative therapy for pediatric intractable epilepsy.

AB - OBJECTIVE: To present our experience with vagus nerve stimulation (VNS) and to evaluate the long-term efficacy and safety of the procedure in pediatric intractable epilepsy. METHODS: This study included sixteen patients, who were implanted with a vagus nerve stimulator and could be followed up for at least more than 12 months in two epilepsy centers. Data including seizure frequency, EEG, quality of life measures and adverse events were prospectively filed over a 5-year period. RESULTS: VNS resulted in a > 50% reduction in seizure frequency in 50.0% (8/16) of children with 31.3% (5/16) of patients achieving a > 90% reduction. Additionally, enhancements in quality of life were as follows: memory in 50.0% (8/16), mood in 62.5% (10/16), behavior in 68.8% (11/16), alertness in 68.8% (11/16), achievement in 37.5% (6/16), and verbal skills in 43.8% (7/16) of the patients. Adverse events included hoarseness in two patients, dyspnea during sleep in two patients, and sialorrhea in one patient. However, these events were tolerable or could be controlled by the adjustment of output currents. In one patient, wound revision was required. CONCLUSION: Our data supports the role of VNS as an alternative therapy for pediatric intractable epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=34248347447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248347447&partnerID=8YFLogxK

M3 - Article

VL - 99

SP - 93

EP - 96

JO - Acta Neurochirurgica, Supplement

JF - Acta Neurochirurgica, Supplement

SN - 0065-1419

ER -